Thomas Amiel
Impact in
-
- Renal cell carcinoma treatment
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
-
- Radiomics and Machine Learning in Medical Imaging
- MRI in cancer diagnosis
Papers in
-
- Renal cell carcinoma treatment 6
- Prostate Cancer Diagnosis and Treatment 5
- Prostate Cancer Treatment and Research 3
- Renal and Vascular Pathologies 2
- Urology 2
- Urinary Bladder and Prostate Research 2
- Co-authors
- Tobias Maurer (4 shared papers)Isabel Rauscher (3 shared papers)Hui Wang (2 shared papers)Wolfgang Andreas Weber (3 shared papers)Matthias Eiber (3 shared papers)Thomas D Horn (3 shared papers)Nassir Navab (1 shared paper)Dimitris Visvikis (2 shared papers)
- Journals
- World Journal of Urology (4 papers)European Urology Oncology (2 papers)European Journal of Nuclear Medicine and Molecular Imaging (1 paper)Cancers (1 paper)European Urology Focus (1 paper)
- Partner nations
- GermanyItalyUnited States
In The Last Decade
Thomas Amiel
16 papers receiving 287 citations
Peers
Comparison fields: 5 of 27
- Pulmonary and Respiratory Medicine 213
- Radiology, Nuclear Medicine and Imaging 71
- Cancer Research 20
- Oncology 18
- Urology 4
Countries citing papers authored by Thomas Amiel
This map shows the geographic impact of Thomas Amiel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Amiel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Amiel more than expected).
Fields of papers citing papers by Thomas Amiel
This network shows the impact of papers produced by Thomas Amiel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Amiel. The network helps show where Thomas Amiel may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Amiel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 72 | |
| 2 | 2020 | 38 | |
| 3 | 2022 | 30 | |
| 4 | 2021 | 27 | |
| 5 | 2019 | 26 | |
| 6 | 2020 | 26 | |
| 7 | 2019 | 25 | |
| 8 | 2021 | 23 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 5 | |
| 11 | 2020 | 4 | |
| 12 | 2021 | 2 | |
| 13 | 2024 | 2 | |
| 14 | Preliminary evaluation of PSMA PET/MR radiomics for primary staging in patients with prostate cancer | 2019 | 1 |
| 15 | 2025 | 1 | |
| 16 | 2025 | 1 | |
| 17 | 2020 | 0 | |
| 18 | 2025 | 0 |
About Thomas Amiel
Thomas Amiel is a scholar working on Pulmonary and Respiratory Medicine, Urology, Surgery, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 18 papers that have together received 288 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (6 papers), Prostate Cancer Diagnosis and Treatment (5 papers), Prostate Cancer Treatment and Research (3 papers), Renal and Vascular Pathologies (2 papers), Urinary Bladder and Prostate Research (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Renal and related cancers (1 paper) and Urinary and Genital Oncology Studies (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (213 citations), Radiology, Nuclear Medicine and Imaging (71 citations), Cancer Research (20 citations), Oncology (18 citations) and Urology (4 citations). Thomas Amiel has collaborated with scholars based in Germany, Italy and United States. Frequent co-authors include Tobias Maurer, Isabel Rauscher, Hui Wang, Wolfgang Andreas Weber, Matthias Eiber, Thomas D Horn, Nassir Navab, Dimitris Visvikis, Mathieu Hatt and Andrei Gafita. Their work appears in journals such as World Journal of Urology, European Urology Oncology, European Journal of Nuclear Medicine and Molecular Imaging, Cancers and European Urology Focus.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.